Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1996 | 09-1996 | 06-1996 | 03-1996 | |
| Sales | 5,870 | 250 | 0 | 3,000 |
| Gross Profit | 5,870 | 250 | N/A | 3,000 |
| Operating Income | 5,870 | 250 | N/A | 3,000 |
| Interest Expense | 0 | 129 | 0 | 0 |
| Other Income | 0 | -5,216 | 0 | 0 |
| Pre-tax Income | 5,870 | -5,094 | 0 | 3,000 |
| Net Income Continuous | -1,199 | -5,094 | -5,441 | -2,194 |
| Net Income | $-1,199 | $-5,094 | $-5,441 | $-2,194 |
| EPS Basic Total Ops | -1,559.69 | -7,798.44 | -8,398.32 | -3,359.33 |
| EPS Basic Continuous Ops | -1,498.75 | -7,277.14 | -9,068.33 | -3,656.67 |
| EPS Diluted Total Ops | -1,559.70 | -7,798.45 | -8,398.30 | -3,359.35 |
| EPS Diluted Continuous Ops | -1,498.75 | -7,277.14 | -9,068.33 | -3,656.67 |
| EBITDA(a) | $5,870 | $250 | $N/A | $3,000 |